Trial of Herb Yuyang Ointment to Diabetic Foot Ulcer

NCT ID: NCT00839865

Last Updated: 2009-02-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-11-30

Study Completion Date

2011-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if dressing change with a kind of herb Yuyang ointment is clinically more efficacious and safer than Conventional treatment in the treatment of diabetic foot ulcers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Developing a Document Retrieval strategy for clinical trials of Chinese medicine treatment of diabetic foot ulcer according to the research program(finished)
2. Selecting and Evaluating the above trials,developing a methodological quality evaluation criteria(finished)
3. extract information, verification, meta-analysis, sensitivity analysis and sub-group analysis(finished)
4. comprehensive evaluating the pros and cons evidences of traditional Chinese medicine, acupuncture and Chinese and Western combined medicine with the treatment of diabetic foot of (finished)
5. we find dress change with a certain kind of herb ointment is very effective and safe to diabetic foot ulcers.The following step is randomized controlled multicenter clinical trial to verify it's efficacy and safety

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetic Foot Ulcer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

herb ointment dressing change group

This group of patients in the ointment dressing every 2 days until Wound Healing or 6 months

Group Type EXPERIMENTAL

herb ointment

Intervention Type DRUG

a kind of ointment made from herb

Conventional dressing change group

This group of patients in the Conventional dressing every 2 days until Wound Healing or 6 months

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

herb ointment

a kind of ointment made from herb

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

TANGZUYUYANGGAO

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* In-patient or out-patient patients diagnosed with diabetic foot ulcers
* Gangrene or ulceration occurred more than 3 weeks
* Over 18 years of age
* Gender-open
* The type of diabetes (type 1 or type 2) open
* Patients receive a written informed consent to participate in the trial

Exclusion Criteria

* Serious complications of heart, liver, lung, kidney damage
* Malignant tumors
* Allergy for Chinese medicine used
* Pregnant women and breast-feeding women
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beijing University of Chinese Medicine

OTHER

Sponsor Role collaborator

Third Military Medical University

OTHER

Sponsor Role collaborator

Guiyang No.1 People's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Guiyang No.1 People's Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Li Shufa, doctor

Role: STUDY_CHAIR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

endocrinology unit,No.1 people's hospital of Guiyang City

Guiyang, Guizhou, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Li Shufa, Doctor

Role: CONTACT

+86 13885007886

Liu Jianping, Doctor

Role: CONTACT

+86 13718004410

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Li ShuFa, Doctor

Role: primary

+86 0851 5833059

Liu JianPing, Doctor

Role: backup

+86 13718004410

References

Explore related publications, articles, or registry entries linked to this study.

Leung PC, Wong MW, Wong WC. Limb salvage in extensive diabetic foot ulceration: an extended study using a herbal supplement. Hong Kong Med J. 2008 Feb;14(1):29-33.

Reference Type BACKGROUND
PMID: 18239240 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ISRCTN20081114

Identifier Type: -

Identifier Source: secondary_id

NCI-197-4128D

Identifier Type: -

Identifier Source: secondary_id

R01-020225-1

Identifier Type: -

Identifier Source: secondary_id

SFL-2008-11

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treatment of Diabetic Foot Ulcers With AUP1602-C
NCT04281992 COMPLETED PHASE1/PHASE2